title: Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue.
abstract: We investigated whether there is any relationship between biochemical and clinical parameters of migraine and methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism, associated with the migraine subtypes, symptoms, and gender. A total of 150 migraine patients with and without aura (MA and MO) and 107 non-sufferers were included in the study. Biochemical and clinical parameters were measured and genetic analysis was performed. The MTFHR C677T genotype was significantly higher in the migraine group (p = 0.000). The CT genotype frequency of individuals with a family history of migraine was significantly higher (p = 0.025). This genotype frequency was higher in patients who suffer from compression, allodynia, fatigue, and sleeplessness (p = 0.027, 0.023, 0.006, and 0.05, respectively). Homocysteine and total cholesterol levels were significantly higher in the migraine group than the control group (p = 0.007 and 0.010, respectively). However, the other biochemical and clinical parameters did not differ from each other (p > 0.05), with only attack frequency being significantly higher in the MO group (p = 0.005). While the folate and HDL levels were significantly higher in females (p = 0.001 and 0.000, respectively), the homocysteine and triglyceride levels were significantly higher in males (p = 0.000 for each one). BMIs were significantly lower in the control than the migraine group (p = 0.021); however, an association between the C677T variant and BMI was not found (p = 0.787) in the migraine group. An association between the MTHFR C667T polymorphism and migraine susceptibility was found. Additional studies including genetic, clinic, and biochemical parameters should be conducted to better understand the disease.
authors: Department of Biophysics, Medical School, Duzce University, Duzce, 81620, Turkey, anzel78@hotmail.com.
authors: Anzel
authors: A
authors: Bahadir
authors: Recep
authors: R
authors: Eroz
authors: Suber
authors: S
authors: Dikici
mesh_terms: D000328:Adult; D000483:Alleles; D016022:Case-Control Studies; D004587:Electrophoresis, Agar Gel; D005221:Fatigue / Q000150:complications / Q000201:enzymology / Q000235:genetics*; D005260:Female; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D006930:Hyperalgesia / Q000150:complications / Q000235:genetics*; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D008881:Migraine Disorders / Q000150:complications / Q000201:enzymology* / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D014421:Turkey
chemical_list: C573423:MTHFR protein, human; D042965:Methylenetetrahydrofolate Reductase (NADPH2)
references: J Clin Invest. 1996 Jul 1;98(1):24-9
references: 8690798
references: Curr Opin Pharmacol. 2003 Feb;3(1):73-7
references: 12550745
references: Headache. 2001 Sep;41(8):779-81
references: 11576202
references: BMC Res Notes. 2010 Jul 28;3:213
references: 20663228
references: J Neurol Sci. 2009 Feb 15;277(1-2):133-7
references: 19081115
references: Nutrition. 2003 Jul-Aug;19(7-8):686-92
references: 12831960
references: Cephalalgia. 1993 Aug;13(4):245-8
references: 8374938
references: BMJ. 2002 Nov 23;325(7374):1202
references: 12446535
references: Brain Res Brain Res Rev. 2005 Jun;48(3):438-56
references: 15914251
references: Cephalalgia. 2009 Jun;29(6):662-9
references: 19210514
references: Cephalalgia. 2009 Sep;29(9):960-8
references: 19298544
references: Dis Markers. 2008;25(2):107-13
references: 18957721
references: Ann Neurol. 2006 Nov;60(5):621-622
references: 16800002
references: Ann Neurol. 2006 Feb;59(2):372-5
references: 16365871
references: Am J Med. 2005 Mar;118 Suppl 1:3S-10S
references: 15841882
references: Annu Rev Nutr. 1999;19:217-46
references: 10448523
references: Headache. 2010 Apr;50(4):631-48
references: 19845784
references: Neurol Sci. 2007 May;28 Suppl 2:S220-1
references: 17508175
references: Neurology. 2006 Feb 28;66(4):545-50
references: 16354886
references: Cephalalgia. 2010 Apr;30(4):447-56
references: 19673907
references: Lancet Neurol. 2002 Sep;1(5):285-93
references: 12849426
references: Cephalalgia. 2008 Dec;28(12):1270-6
references: 18727641
references: Neurol Sci. 2008 May;29 Suppl 1:S173-5
references: 18545927
references: Headache. 2012 Mar;52(3):515-20
references: 22375693
references: Ann Neurol. 1997 Feb;41(2):166-72
references: 9029065
references: Brain Res Mol Brain Res. 2005 Sep 13;139(1):163-8
references: 15953655
references: BMC Med. 2004 Feb 12;2:3
references: 15053827
references: Brain Res Mol Brain Res. 2003 Mar 17;111(1-2):84-90
references: 12654508
references: Cephalalgia. 2009 Aug;29(8):818-25
references: 17714520
references: Cell Biochem Funct. 2005 Jan-Feb;23(1):51-4
references: 15386535
references: Cephalalgia. 1988;8 Suppl 7:1-96
references: 3048700
references: Cephalalgia. 2006 Dec;26(12):1462-72
references: 17116097
references: Nat Genet. 1995 May;10(1):111-3
references: 7647779
references: Cephalalgia. 2004 Jun;24(6):491-4
references: 15154859
references: Headache. 2010 Jan;50(1):99-168
references: 19619240
references: Headache. 2011 Jun;51(6):880-90
references: 21631474
references: Neuroreport. 2006 Jan 23;17(1):61-4
references: 16361951
references: Mol Genet Metab. 2006 Jun;88(2):107-13
references: 16403664
references: Twin Res. 2003 Oct;6(5):422-31
references: 14624726
references: Am J Med Genet. 2000 Dec 4;96(6):762-4
references: 11121176
references: Res Nurs Health. 1990 Aug;13(4):227-36
references: 2197679
references: Cephalalgia. 2009 Feb;29(2):269-78
references: 19143772
references: Neurology. 2008 Aug 12;71(7):505-13
references: 18672474